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ABSTRACT The fluorescent probe anilinonaphthalene-8-sulfonate binds to adipocyte lipid binding protein at a site that
competes with normal physiological ligands, such as fatty acids. Binding to the protein is accompanied by a relatively large
increase in fluorescent intensity. To correlate the major change in optical properties and to determine the mechanism of
competitive inhibition with fatty acids, the crystal structure of the protein with the bound fluorophore has been determined.
In addition, the thermodynamic contributions to the binding reaction have been studied by titration calorimetry. Because the
binding site is in a relatively internal position, kinetic studies have also been carried out to determine kon. The results indicate
that binding is not accompanied by any major conformational change. However, the negatively charged sulfonate moiety is
not positioned the same as the carboxylate of fatty acid ligands as determined in previous studies. Nonetheless, the binding
reaction is still driven by enthalpic effects. As judged by the crystallographic structure, a significant amount of the surface of
the fluorophore is no longer exposed to water in the bound state.
INTRODUCTION
Intracellular lipid binding proteins (iLBPs) have the unusual
property of having a hydrophobic ligand binding site within
a water-filled cavity inside an underlying -barrel structure.
A fluorescent probe, 1-anilinonaphthalene-8-sulfonate
(ANS) has been shown to be a competitive inhibitor for
binding of the most prevalent ligand, fatty acids (Kane and
Bernlohr, 1996; Kurian et al., 1996). ANS is also a com-
monly used probe employed to observe the character of
different regions of globular and membrane proteins (Slavik
et al., 1982). Its covalent structure is illustrated in Fig. 1.
Crystallographic studies of the bound form of ANS would
provide some insight into what binding environment led to
changes in ANS fluorescence.
Binding of ANS to several different iLBP family mem-
bers shows that there is a large fluorescent enhancement
accompanied by a blue spectral shift. The binding of ANS
to proteins belonging to the iLBP family includes studies of
intestinal and adipocyte fatty acid binding proteins, cellular
retinol binding protein, and cellular retinoic acid binding
protein (I). In all of the iLBP family members, the emitted
intensity maximum is shifted from 525 nm to 470 nm
(Kane and Bernlohr, 1996; Kurian et al., 1996). For intes-
tinal fatty acid binding protein, the ratio of the quantum
yield for the bound versus free ANS in aqueous solution is
of the order of 160 (Kirk et al., 1996). Recognizing some
small variation, the fluorescent enhancement experienced
by the fluorescent probe appeared to be similar for the fatty
acid and retinoic acid binding proteins, but was reduced by
1⁄2 for the cellular retinol binding protein.
The two binding studies mentioned above established the
stoichiometry as one ANS per iLBP molecule (Kane and
Bernlohr, 1996; Kurian et al., 1996). Since the binding
cavity for the fatty and retinoic acid binding proteins con-
tains two buried arginines that interact with the carboxylate
of the hydrophobic ligands, it is reasonable to expect the
sulfonate moiety of ANS to locate near these arginine side
chains. In the retinol binding proteins, where the ligand is
neutral, these two internalized arginine sites are present as
glutamines (Banaszak et al., 1994). ANS still binds to
cellular retinol binding protein, but with a lower affinity and
a reduced fluorescent enhancement.
The dissociation constants for ANS binding to the fatty
acid binding proteins ranged from500 nM to 5 M. In the
case of intestinal fatty acid binding protein, ANS binding
was also studied by isothermal titration calorimetry (Kirk et
al., 1996). The KD values determined by the two methods
were in general agreement. The calorimetric analysis pro-
duced a value for H and indicated that most of the binding
energy was derived from the enthalpic contribution. The
chemical studies also demonstrated that the binding of ANS
to the iLBPs competes with fatty acid binding. This then
suggests that the location of the ANS binding site is within
the cavities of the iLBPs. The competitive nature of ANS
binding also made it possible to study fatty acid affinity
(Kane and Bernlohr, 1996; Kurian et al., 1996).
While the use of ANS as a conformational probe contin-
ues to increase, few detailed structural data are available on
the factors contributing to the changes in fluorescent prop-
erties. A single crystallographic study describes the binding
of ANS to -chymotrypsin in both solution and crystalline
environments (Weber et al., 1979; Johnson et al., 1979). The
fluorescent enhancement for ANS bound to -chymotrypsin
appears to be similar to that observed upon binding to the
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iLBPs, but was strongly pH-dependent (Weber et al., 1979).
The crystal structure demonstrated that ANS was bound at
a surface site. In this unrefined crystallographic study of the
chymotrypsin complex, the aniline-ring was approximately
coplanar with that of the naphthalene moiety (Weber et al.,
1979).
The quantum yield and fluorescent lifetime of a bound
fluorophore are highly dependent on the absence of nonra-
diative transitions (Slavik et al., 1982). The very high quan-
tum yields for ANS bound to adipocyte lipid binding pro-
teins (ALBP) and intestinal fatty acid binding protein
(IFABP) suggest that the pathways of energy transfer
through excited state interactions have been limited, most
likely by a partial occlusion of the ANS from bulk solvent.
In the crystallographic analysis that follows, the conforma-
tion and interactions of ANS with the protein ALBP are
analyzed in detail. The ALBP crystals contained two mol-
ecules per asymmetric unit and a comparison between the
conformations of the two ANS molecules will be given.
Additionally, a comparison between the ANS conforma-
tions as bound to chymotrypsin and ALBP will be made.
Finally, characterization of the ALBP/ANS reaction using
isothermal titration calorimetry and stopped flow kinetics
will be presented. The kinetic results proved complex, and
could not be explained by a pseudo-first-order reaction.
MATERIALS AND METHODS
Expression, purification, and preparation
of co-crystals
Native murine ALBP was expressed and purified as previously reported
(Xu et al., 1991). Pure ALBP was concentrated to 10 mg/ml in 12.5 mM
HEPES pH 7.2, 50 mM NaCl. The NH4
 salt of ANS was dissolved in 12.5
mM HEPES pH 7.2, 50 mM NaCl, and the concentration verified spec-
trophotometrically (280  4990 M
1 cm1). This ANS stock was added
to the ALBP solution so a 2:1 ANS/ALBP stoichiometry was achieved
without significant dilution of the ALBP. The incomplete factorial and
novel matrix methods of crystallization screening were employed (Carter
and Carter, 1979; Jancarik and Kim, 1991) using the vapor-diffusion/
hanging drop procedure. Crystals formed at 0.1 M HEPES pH 7.5, 2% v/v
PEG 400, and 2.0 M (NH4)2SO4.
X-ray methods
X-ray diffraction data were collected at room temperature on a Siemens
multiwire area detector, with CuK radiation from a Rigaku RU-200
generator equipped with a graphite crystal monochromator. Data were
collected with a crystal to detector distance of 11.7 cm and a crystal
rotation of 0.25° between frames. Data collection statistics are reported in
Table 1. The XENGEN suite of programs was used to process the initial
data and determine the space group.
Model refinement
Starting phases were derived from the coordinates obtained from an iso-
morphous crystal form of ALBP modified with a pyridoxamine group (Ory
et al., 1998). Coordinates of the pyridoxamine moiety were removed, and
further refinement of the structure was carried out in X-plor (Brunger et al.,
1987), with initial rigid body refinement being followed by simulated
annealing (Brunger, 1988). Multiple rounds of positional and B-factor
refinement were accomplished using a bulk-solvent correction (Jiang and
Brunger, 1994). The ANS was added to the structure and fit to both
2Fo-Fc maps contoured at 1 and Fo-Fc maps contoured at 3. Waters
were placed in the model late in refinement, and had to be present in both
2Fo-Fc maps contoured at 1 and Fo-Fc maps contoured at 3. The
water sites were required to be between 2.5 Å and 3.5 Å away from a
proper hydrogen bond donor/acceptor atom. The Rfactor/Rfree was moni-
tored at all stages in refinement to ensure proper fitting and building of the
model (Brunger, 1992). Final refinement statistics are presented in Table 1.
All cavity volume measurements were calculated using the algorithm
CAST (Liang et al., 1998) and manually inspected for cavity continuity.
For cases where NMR structures existed, all volumes of all reported
structures were averaged, and standard deviations reported.
Stopped-flow measurements of
ALBP/ANS reaction
Kinetic data for the binding reaction were collected on an Applied Photo-
physics SX.18MV stopped-flow reaction analyzer interfaced to an Acorn
FIGURE 1 Electron density maps
of ANS. A simulated annealing omit
map (left), and final omit map (right),
both contoured at 3, illustrating the
initial ambiguity of the maps. The
C1–N–C1–C2 atoms are labeled for
reader reference, especially to Table 2.
1108 Biophysical Journal Volume 77 August 1999
RiscPC. Both protein and ligand samples were in 20 mM Na/K phos-
phate buffer, pH 7.2, and their concentrations verified spectrophotometri-
cally. ALBP was delipidated before data acquisition by treating with
Lipidex resin at 37°C using a batch method. For the stopped-flow study,
the protein syringe contained ALBP in phosphate buffer at 10 M, with the
ligand syringe containing increasing amounts (40, 60, 80, 100, 200, 300,
400, 500, 600, and 700 M) of ANS in phosphate buffer. ANS fluores-
cence was monitored using an excitation wavelength of 380 nm and an
emission wavelength of 475 nm. Voltage to the photomultiplier was held
constant throughout the data acquisition, and all runs adjusted to a common
endpoint to account for native ANS fluorescence. This was verified inde-
pendently with ANS and buffer alone for initial runs. Runs were collected
five times over a logarithmic time scale and averaged by the data collection
software. Initial runs were carried out at 25°C, but it was observed that the
majority of the reaction was complete (75% of the calculated maximal
amplitude change) in the dead time, even at the lower ANS concentrations.
The runs were then repeated at 4°C to better observe the fastest process. All
runs were carried out in dim light conditions, and solutions were allowed
to equilibrate to 4°C before data acquisition.
Data manipulation of stopped-flow results
The raw data were shifted by the dead time of 2 ms (Tonomura et al.,
1978). The data were fit to one, two, and three exponential equations using
KFIT (Neil Millar, ftp://wuarchive.wustl.edu/packages/kinsim/uploads).
The KINSIM (Dang and Frieden, 1997) suite of programs and KSIM (Neil
Millar) were used to test potential models and fit the data. The reaction was
assumed to start at the same zero time point for fitting to all equations. This
was done to accommodate the observance that more and more of the fastest
reaction disappeared in the dead time of the instrument as ligand concen-
tration increased.
Isothermal titration calorimetry of the
ALBP/ANS reaction
Calorimetric analysis was carried out on a Microcal (Northampton, MA)
calorimeter. 35.5 M ALBP in 20 mM Na/K phosphate buffer, pH 7.2,
cell volume 1.3438 ml, was titrated with 15-l injections of 439 M ANS
in the same buffer using 15 s per injection and a stirring rate of 400 rpm.
All titration runs were followed with reference runs of 439 M ANS
injected into buffer alone. The reference runs were then fit to a linear
function, and the line subtracted from the raw data to account for heat of
dilution and temperature differences between the injection syringe and the
bath. Protein and ANS concentrations were verified spectrophotometrically
before data fitting, as the enthalpy of binding and the stoichiometry of the
reaction is sensitive to the ligand concentration used to fit the data. The raw
data were integrated and processed with the Origin 2.9 suite of programs.
RESULTS
Crystallographic analysis of ALBP/ANS complex
General characteristics of the crystallographic data and
model results are given in Table 1. As indicated by the value
for Rmerge, multiple measurements of the same reflections
agreed within a satisfactory range. The resolution extended
to 2.55 Å and was 95% complete with an overall I/I value
above 1.0. As mentioned in the Methods section, the phases
were obtained from an isomorphous structure [pdb1a2d.ent
in the Protein Data Bank (PDB)]. An Fo-Fc map was not
useful, as the isomorphous structure contained a chemical
adduct that partially filled the binding cavity, possibly bi-
asing electron density in the region of ANS. Nonetheless,
electron density for the ANS was present during all stages
of refinement, but was ambiguous in both the 2Fo -Fc and
Fo-Fc maps. To eliminate ambiguity, the ANS was mod-
eled initially in two conformations within the cavity and
refinement carried out in parallel on both structures. After
refinement, the shape of the resultant electron density was
the same regardless of initial ANS orientation. This new
electron density map clearly favored one conformation over
the other. Simulated annealing and final omit maps of the
ANS group are shown in Fig. 1. Though the electron density
is noncontiguous in the simulated annealing omit map con-
toured at 3, it is clearly visible and contiguous when
contoured at 2 (data not shown).
After refinement, all of the atoms in the ALBP polypep-
tide chain were accounted for as well as the presence of
bound ANS, 1 Cl, and 78 water molecules. Since there are
two molecules in the asymmetric unit, a crude approxima-
tion to the precision of the coordinates is apparent from the
RMS difference after superimposing one molecule on an-
other. For C atoms, the RMS difference was 0.22 Å, and
0.96 Å RMS difference using all atoms. The resolution limit
of the data was judged to be of sufficient quality not to
enforce noncrystallographic symmetry restraints to the re-
finement protocol. The crystallographic coordinates for the
ANS/ALBP complex have been deposited in the PDB with
the accession code 2ANS.
The crystallographic results reveal the ANS ligand bound
within the cavity normally occupied by fatty acids. The
TABLE 1 X-ray data and refinement results of crystalline
ALBP/ANS complex
Variable Refinement
Range 24–2.5 Å 2.7–2.5 Å
Collected reflections 74950 3176
Unique reflections 12287 1263
Rmerge 10.2% 31.2%
Space group P212121
Unit cell (a  b  c) 80.8 Å 
96.1 Å 
49.9 Å
Completeness (I/I 	 1.0) 95% 58%
Molecules per asymmetric unit 2
Refinement results
Number of atoms
protein 2034
water 78
ligand 42
nonwater het-atoms 1 Cl ion
Rfactor/Rfree 18.9%/24.7%
B factors (avg.)
main chain 24.1 Å2
side chain 26.6 Å2
ligand (ANS) 73.8 Å2
waters 36.5 Å2
RMS bond length (Å) 0.007
RMS bond angle (deg) 1.581
Overall G-factor 0.2
Bad contacts 0
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overall positioning of ANS relative to the C backbone
model of ALBP is illustrated in Fig. 2. Essentially identical
results are obtained independent of which of the two protein
molecules in the crystal are observed. Note in Fig. 2 that all
of the atoms of the ligand are within the strands of the
ALBP -barrel. Fig. 2 also contains a ball-and-stick repre-
sentation of the long-chain sulfonate, hexadecane sulfonic
acid (HDS), obtained from a different crystallographic anal-
ysis (LaLonde et al., 1994a). The coordinates of HDS were
placed in the crystallographic coordinates of the ANS-
ALBP complex using least-squares methods. Note that a
number of the atoms belonging to ANS are in similar
positions to those belonging to a fatty acid ligand.
Despite clear overlap between the binding site for ANS
and previously determined positions for fatty acids, the
ANS site is in a significantly different orientation. Essen-
tially, it is “flipped” from the orientation that we expected it
to adopt with the negative sulfonate headgroup pointing
more toward the portal region. This is the area capped by the
C-D and E-F loops and helix II. It is the aniline ring
of ANS that interacts with the normal carboxylate binding
pair of R126/Y128.
Because of the substantial fluorescent enhancement of
bound ANS, the protein conformation near the ANS in the
crystal structure has been studied in detail. The two mole-
cules in the asymmetric unit were analyzed for van der
Waals and potential polar contacts using the program HB-
PLUS (McDonald and Thornton, 1994). The principal con-
tacts are shown schematically in Fig. 3. Numerous hydro-
phobic contacts with the ANS are made in both molecules,
including an edge-to-face interaction of Phe-16 to the naph-
thyl ring of ANS.
Similar to what was observed in the crystal structure of
-chymotrypsin/ANS (Weber et al., 1979), the interactions
are not strictly hydrophobic. This is not surprising, as the
cavity of ALBP is lined with approximately an equal num-
ber of polar and hydrophobic amino acids, and it would be
difficult for any ligand to make a “strictly hydrophobic”
interaction. Some of the interactions, however, are unusual.
Perhaps most striking is the relatively close interaction of
the benzyl ring of Phe-57 with a sulfonate oxygen of the
ANS. To make this interaction, the main chain of Phe-57
moves 1.87 Å and 2.6 Å toward the binding cavity when
compared to the native-apo or oleate-bound structures of
ALBP, respectively.
Thermodynamic analysis of the
ALBP/ANS reaction
By using isothermal titration calorimetry, the enthalpy of
binding was measured at nine different temperatures, and
the free energy and entropy of binding calculated using the
following equations: G  RTln(Ka), G  H  TS.
The results were then used to compute the heat capacity
changes for the binding reaction. The results are given in
Table 4. The data used to determine the heat capacity are
shown in Fig. 4. The binding reaction had a Cp,220.3

13.4 cal/deg-mol.
The values at 30°C given in Table 4 for ALBP (G 
8.0 and H  9.6 kcal/mol) can be compared to a
similar study by Kirk et al. (1996) utilizing IFABP. Using
titration calorimetry, ANS bound to IFABP had a Kd of 11.4
M at 30°C. The binding reaction for ANS to IFABP gave
values of 7.1 kcal/mol for G and 10.5 kcal/mol for
H. The thermodynamics are clearly very similar, and
therefore the binding reactions and probably the fluorescent
enhancement to both ALBP and IFABP appear to be com-
parable. Since they are homologous proteins, this is not
surprising. However, the binding cavity of IFABP is smaller
than ALBP, which may have some bearing on understand-
ing the structural determinants of the interaction and will be
discussed in more detail in the Discussion section.
Kinetic analysis of the ALBP/ANS reaction
To further characterize the ligand binding reaction, stopped-
flow analysis was performed to determine the reaction rates.
The kinetic studies were carried out at varying concentra-
tions of ANS, and the raw data are shown in Fig. 5 D. The
kinetic data did not satisfactorily fit to a single or double
exponential (data not shown), but were adequately repre-
FIGURE 2 Binding mode of ANS. A cartoon representation of the
crystal structure of ALBP/ANS. ANS is represented as blackened bonds.
The structure of hexadecanesulfonate (HDS)-bound ALBP (pdb1lic.ent)
was superimposed with the ANS bound structure, and the resultant coor-
dinates for HDS shown as a ball-and-stick. Elements of secondary structure
are labeled for reader reference. The portal region is the area between helix
II, the C-D turn, and the E-F turn.
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sented by a three-exponential function. As a result of this
analysis, plots of the three relaxation times as a function of
ANS concentration are shown in Fig. 5, A–C.
The three-step interpretation results in the fastest step
(Fig. 5 A), being pseudo-first-order with respect to ANS.
The second reaction (Fig. 5 B) is again pseudo-first-order
with respect to ANS, but is slower by a factor of 25. The
slowest step is zero order with respect to the fluorescent
probe concentration, as is apparent in Fig. 5 C.
DISCUSSION
The fluorescent enhancement accompanying ANS binding
to ALBP has been observed to varying degrees with many
proteins. The only other crystallographic study examining
the nature of protein interactions with this fluoroprobe in-
volved ANS bound to -chymotrypsin. Weber et al. (1979)
found in solution and in the co-crystal that ANS bound to
-chymotrypsin, but showed fluorescence enhancement
only when the pH dropped below 3.6. The crystal structure
of the ANS-bound complex was solved at both pH 3.6 and
pH 7, and the structure of the ANS analyzed. No pH-
dependent conformational change was found either in the
protein environment surrounding the ANS or in the ANS
itself. The authors mention that a structural change is seen
in -chymotrypsin below pH 5.0, but do not expand on this
finding, nor relate it to ANS binding or fluorescence. As-
suming the structural change is not near the ANS binding
site, this would suggest the fluorescent enhancement is due
to the change in protonation state of the bound ANS and the
different interactions available to the protonated form.
The chymotrypsin study was done before the establish-
ment of the Brookhaven structural database and before
modern x-ray refinement methods, so no coordinates for the
protein-ANS complex are available from the study. The
authors did list the coordinates of the ANS alone when
FIGURE 4 Determination of specific heat capacity of the ALBP/ANS
reaction. The enthalpy of the binding reaction is plotted as a function of
temperature. The error bars indicated at each measurement are the result of
errors in fitting a standard binding isotherm to the data obtained from the
calorimeter.
FIGURE 3 ANS interaction sites on ALBP. Principal interaction sites between ANS and ALBP are shown schematically. Two sites are displayed
representing the two ALBP molecules found in the asymmetric unit of the crystalline complex. The spikes emerging from both protein and ligand atoms
denote nonpolar contacts. The interaction between R126 and an oxygen atom of ANS is near the limit of detection of the searching algorithm for one of
the ALBP molecules, and therefore appears in only one molecule, ANS 1(D). The analyses and drawing were done with LIGPLOT.
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FIGURE 5 Relaxation times of the ALBP/ANS reaction. Raw stopped-flow data (D) were fit to a three-exponential equation, and observed rate constants
plotted as a function of final ligand concentration (A–C). Error bars represent errors of fitting.
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bound to -chymotrypsin. We have used them to compare
the structure of ANS bound to chymotrypsin, to ALBP, and
the crystal conformation of ANS itself. Two angles may be
used to describe most of the conformation of the ANS; they
are listed in Table 2. The values of  (dihedral angle
between the naphthyl and anilino ring) and the torsional
angle defined by C11–N–C1–C2 are reported. The values
for molecule A in the small molecule study is roughly
similar to the two values of these angles when the ANS is
bound to ALBP and to ANS alone, as described in the
Weber and Tulinsky report. The similarity between the
bound and unbound conformations suggests that the fluo-
rescent enhancement found on binding to a protein is not
related to the conformation of the fluorophore, but rather the
energy pathways available between the excited state and its
surroundings, chiefly bulk solvent.
With -chymotrypsin, ANS binds to a surface site; in
binding to ALBP, it is located within a cavity. To see
whether any detectable changes occurred, the cavity vol-
umes of both ALBP molecules were calculated using the
CAST algorithm (Liang et al., 1998). These data were then
compared to all previously solved structures of ALBP,
including studies of the protein with long-chain fatty acids,
and the results are shown in Table 3. Volume calculations
have suggested increases in cavity volume as a result of
ligand binding to iLBPs (LiCata and Bernlohr, 1998). In the
case of the crystal structure of the ANS/ALBP complex, no
such expansion occurs. The cavity volumes of apo-ALBP
and ANS bound to ALBP are almost identical, perhaps
somewhat smaller. Hence, the relatively small volume ex-
pansion observed with ALBP and other iLBPs and accom-
panying fatty acid binding does not occur with ANS. This
means that the number of internalized solvent molecules is
approximately the same for complexes of ALBP with the
fluoroprobe and more physiological ligands such as fatty
acids.
The crystal structure of ANS bound to ALBP reveals an
unusual and previously unseen ligand-binding mode for the
iLBP family. The negatively charged headgroup of ANS,
instead of being coordinated by the R106/Y128/R126 bind-
ing triad, interacts with mostly hydrophobic side chains
inside the cavity. The only ionic interaction is a weak
electrostatic bond between a terminal nitrogen atom of
R126 and an oxygen atom of the sulfonate moiety 3.1 Å
away. While the binding mode is unusual, it may be due to
the nature of the ligand. This structure is the first of its kind
with a significant aromatic component bound to a member
of the iLBP family.
A comparison of the ANS/ALBP crystal structure with
coordinates for other complexes of ALBP was done. It is
immediately obvious that ANS and a fatty acid ligand could
not occupy the ligand-binding cavity at the same time;
considerable atomic overlap exists between portions of the
bound ligands (the reader is referred to Fig. 2). It is also
apparent that the location of the sulfonate of ANS and the
carboxylates of fatty acids is different. The crystallographic
studies indicate that ANS and fatty acid ligands “partially
compete.” The negative aspect of the structural results is
that dissociation constants determined for fatty acid binding
by competition with ANS are technically inhibitory con-
stants (Ki), not dissociation constants. They will rely heavily
on accurate determination of the binding constant of the
ALBP/ANS reaction.
To further explore the binding reaction, isothermal titra-
tion calorimetry was used on the ALBP/ANS reaction to
determine H and Kd. The results are given in Table 4. The
reaction is entropically opposed above 25.0°C, but this
effect is compensated for by a large enthalpy of binding at
higher temperatures. This higher enthalpy is a bit unusual
due to the lack of any significant ionic interaction similar to
those seen for fatty acids. This may call for a slight reeval-
uation of the binding energy terms of the binding reaction
for physiological ligands. LaLonde et al. (1994b) suggested
that the majority of the favorable enthalpic binding energy
stems from the coulombic interactions of the negative fatty
acid headgroup with the positive groups R126 and a water-
bridged R106. ANS, however, has an interaction with R126
TABLE 2 Angles defining ANS conformations
ANS Structure C11–N–C1–C2 *
ALBP ANS A# 78° 64°
ALBP ANS B# 76° 57°
-CHT ANS A# 10° NR§
-CHT ANS B# 27° NR§
Weber & Tulinsky 43° 61°
Cody & Hazel A# 22° 63°
Cody & Hazel B# 46° 127°
The C11–N–C1–C2 angle is a torsional angle. See Fig. 3.
*Defined as the dihedral angle between the plane of the anilino ring and the
plane of the naphthyl ring.
#A and B indicate more than one conformation, or more than one molecule
per asymmetric unit. Weber and Tulinsky, and Cody and Hazel derived the
angles from the crystal structures of unbound ANS.
§Not reported due to spherical averaging of density.
TABLE 3 Volume comparisons for the ALBP
ligand-binding cavity
Protein Comment Volume (Å3) Average
ALBP
1ALB Apo 1039.4 1005.35 
 48.2
1LIB Apo 971.3
1LIC Hexadecanesulfonate 1096.4 1113.3 
 18.2
1LID Oleate 1125.8
1LIE Palmitate 1108.5
1LIF Stearate 1092.0
1ADL Arachidonate 1133.8
1AB0 Mutant, pH 4.5 1016.8 1169.3
 215.6
1ACD Mutant, pH 6.4 1321.7
ANS-
A
ANS, Mol A 932.2 908.4
 33.6
ANS-B ANS, Mol B 884.6
The volumes were calculated with the CAST algorithm, and visually
inspected for continuity (Liang et al., 1998). All volumes are the “Vol ms”
from CAST. They represent a volume “cast” from molecular surface of the
crystal structure of ALBP without any ligand.
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that is weak at best, makes extensive nonpolar contacts with
the binding cavity, and yet has a very high enthalpic con-
tribution. Regardless, the thermodynamic binding profile
for ANS is similar to that of other ligands, being driven
mostly by a highly favorable enthalpic energy that is offset
by unfavorable entropy at physiological temperatures.
The large negative heat capacity seen for the ALBP/ANS
reaction is consistent with results seen in the binding of
ANS to a homologous protein, IFABP. The calculated Cp
for the ALBP/ANS reaction is 220 cal/deg-mol, while
the Cp for the IFABP/ANS reaction is 283 cal/deg-
mol (Kirk et al., 1996). Furthermore, the overall thermody-
namic profile is similar for IFABP bound to ANS; the
IFABP/ANS reaction is entropically opposed above 15°C,
while the ALBP/ANS reaction is entropically opposed
above 25°C. Kirk et al. suggest that this negative change in
the heat capacity in the case of IFABP is due mostly to the
loss of internal hydrogen bonds of waters found in the
cavity that are displaced by the ligand (Kirk et al., 1996).
The authors further suggest the degrees of freedom avail-
able to cavity waters are fewer when ligand is bound,
helping to increase the entropic opposition. Unfortunately,
current structural work offers no insight into this possibility.
Comparison of the apo-ALBP structure (1LIB in the
PDB) to the ALBP/ANS structure reveals one crystallo-
graphically ordered water in the apo state that would theo-
retically be displaced by ANS binding. The binding of any
ligand must displace more than one water molecule. How-
ever, the lack of ordered water molecules observed in the
ANS region in other ALBP crystal structures suggests that
water molecules in this area of the cavity are more highly
exchangeable. The entropic opposition to binding can also
be explained if the dominant part of S is due to ANS and
its more rigid conformation when bound to the protein than
when free in solution.
After verifying that ANS could be used as an accurate
measure of the ligand binding reaction, the fluorescent
properties of ANS were exploited to explore the kinetics of
the binding reaction. Since the static model of ALBP has the
binding site within a cavity, various ideas have been offered
as to the mechanism of binding. The best way to study the
native ligand binding reaction would be to monitor native
tryptophan fluorescence transiently in response to added
fatty acid, as was done in the case of IFABP (Cistola et al.,
1996). However, previous studies have shown little to no
change in the native tryptophan spectra of ALBP in re-
sponse to various fatty acids (Bernlohr and Simpson, per-
sonal communication). Instead, the ALBP/ANS reaction
was followed using stopped-flow methods.
Interestingly, the stopped-flow data exhibited behavior
that suggested a complex binding mechanism consisting of
two relaxation times dependent on ANS concentration (k1
obs
and k2
obs in Fig. 5, A and B), with an event whose relaxation
time was most likely not dependent (k3
obs in Fig. 5 C) on the
ANS concentration. The number of reaction mechanisms
that may accommodate three reaction times is great. That
being said, previous biochemical evidence can help to rule
out most mechanisms. Two ligand-dependent relaxation
times could be indicative of two binding sites. However,
isothermal titration calorimetry and crystallography clearly
show a binding stoichiometry of one, and so the second site
would have to be extremely weak (in the mM range).
Furthermore, all reaction mechanisms that incorporated ir-
reversible steps were eliminated, as the binding constant is
not strong enough (1 M) to be treated as such, nor has
any part of this reaction been shown to be irreversible.
Attempts to globally fit the kinetic data to numerous other
models were unreliable. This is primarily due to the fact that
a single observable, the fluorescent signal of the ANS, is
being fit to at least six variables in a mechanism involving
two intermediates. Accurate global fits require a higher ratio
of observable species to variables to be meaningful. For
example, the three different rates could be due to different
binding environments within the cavity. Then the final rate
was the convergence to a single binding site resembling that
seen in the crystal. Fitting of this mechanism, however,
would require the fluorescent coefficients of the intermedi-
ate species, which are unknown.
The observed rates nevertheless indicate a process that
behaves similarly to the expected pseudo-first-order behav-
ior of a simple binding reaction. This is additive with two
other processes. The first process is dependent on ligand
TABLE 4 Thermodynamic parameters for the ALBP/ANS reaction
Temp.
(°C)k kd (M) G (kcal/mol) H (kcal/mol) S (e.u.)
10.2 1.9 
 1.0 7.4 
 0.12 5.3 
 0.20 7.4 
 0.8
15.1 1.4 
 0.9 7.7 
 0.14 5.8 
 0.25 6.6 
 1.0
20.1 1.0 
 0.6 8.0 
 0.14 6.4 
 0.21 5.4 
 0.8
25.1 1.2 
 0.8 8.1 
 0.16 7.7 
 0.30 1.3 
 1.1
30.2 1.7 
 1.0 8.0 
 0.14 9.6 
 0.37 5.1 
 1.3
35.1 1.5 
 0.7 8.2 
 0.12 9.5 
 0.28 4.0 
 1.0
40.1 1.6 
 1.2 8.3 
 0.18 10.9 
 0.52 8.4 
 1.8
45.1 2.1 
 0.4 8.3 
 0.05 12.6 
 0.17 13.7 
 0.6
50.1 2.2 
 1.7 8.3 
 0.19 14.0 
 0.74 17.6 
 2.4
The parameters of the binding reaction for temperatures in the range of 10 through 25.1°C were measured with a bath temperature of 5.0°C. For the studies
in the temperatures range of 30.2°C through 50.1°C, a bath temperature of 25.0°C was used. All values are based on a single experiment and the errors
are estimated from the titration data using the Origin 2.9 program. The KD values are based on the stoichiometry of one ANS site per ALBP molecule.
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concentration, an order of magnitude slower than the bind-
ing reaction. The second process appears independent of
ligand concentration, and occurs at1 s1. Further analysis
of this reaction using mutants of ALBP suspected to have
different ligand binding kinetics [such as V32D/F57H (Ory
et al., 1997)] are needed to better characterize this complex
system.
In the kinetics of IFABP binding, a concentration-inde-
pendent process was also seen, which was fit to a structural
isomerization between an open and closed state of the
protein (Cistola et al., 1996). The rate of isomerization was
1000 s1, while the process in the ALBP reaction is 1 s1.
This can be reconciled when two things are taken into
account: 1) the IFABP experiments were performed at
25°C, and the ALBP at 4°C, and 2) 15N relaxation experi-
ments on apo forms of ALBP and IFBAP suggest IFABP is
more flexible than ALBP (Constantine et al., 1998; Hods-
don and Cistola, 1997).
To further test and explore the idea of protein flexibility
in the binding reaction, all crystal structures of native ALBP
solved to date, including the ANS bound structures, were
aligned using LSQMAN (Kleywegt and Jones, 1994), and
analyzed as an ensemble of structures. The results are pre-
sented as a MOLMOL (Koradi et al., 1996) sausage dia-
gram in Fig. 6. The deviations in conformation are much
smaller because they are all crystal structures, and almost all
the entries were refined from the same initial structure.
However, some interesting variations are found. As is
clearly seen in Fig. 6, the areas that deviate in main chain
conformation among the nine structures are localized to the
C-D turn and helix II. These same areas are found to be
disordered on the microsecond-to-picosecond time scale
according to 15N relaxation experiments carried out with
apo form ALBP (Constantine et al., 1998).
It is unclear whether disorder on this time scale can be
correlated with the more discrete disorder seen in apo IF-
ABP structure (Hodsdon and Cistola, 1997). However, this
lends further credence to the concept of these areas being
flexible, as presumably variations in structure found by
crystallography are of a smaller order of magnitude due to
crystal packing forces than those found in well-resolved
NMR structures.
In summary, ANS provides a novel way to measure
dissociation constants using fluorescent methods and com-
petition with physiological ligands such as fatty acids. The
crystal structure of the complex demonstrates the nature of
the competition. ANS is bound to an overlapping region of
the binding cavity seen to interact with fatty acids, but not
in the manner expected. The majority of the binding energy
derives from enthalpic effects apparently due to favorable
nonpolar interactions in the binding cavity. Surprisingly few
ionic interactions between ANS and the protein are seen, the
only obvious one being a weak interaction between R126
and an oxygen atom of the sulfonate headgroup. A mini-
mum of 10 contacts (3.5–4.5 Å) with nonpolar atoms is
made in the crystal structure. Hence, despite the presence of
water within the cavity, the fluoroprobe is clearly not ex-
periencing the same environment as it would in the bulk
solvent. This change in the surrounding environment is
most likely responsible for the fluorescent enhancement.
The kinetics of the binding reaction as followed by fluores-
cent changes is complex, with two processes being additive
with the expected pseudo-first-order binding reaction.
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